chalcone has been researched along with Obesity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, F; Lyu, X; Pan, H; Wang, L; Xu, H; Yan, K; Yang, H; Zhu, H | 1 |
| Gong, F; Jin, M; Liu, M; Pan, H; Wang, L; Wang, X; Yan, K; Yang, H; Zang, B; Zhu, H | 1 |
| Feng, W; Liu, J; Meng, X; Peng, C; Wang, A; Wang, C; Yan, D; Yang, Z; Yue, S | 1 |
| Amoli, MM; Ebrahim-Habibi, A; Jalalvand, F; Kimiagar, M; Yaghmaei, P | 1 |
| Baba, K; Goto, T; Ikutani, R; Jheng, HF; Kawada, T; Li, Y; Lin, S; Murakami, S; Takahashi, H; Takahashi, N; Taniguchi, M; Yu, R | 1 |
| Avril, L; Boussetta, S; Enriquez Vega, DM; Guex, JJ; Taïeb, C | 1 |
1 trial(s) available for chalcone and Obesity
| Article | Year |
|---|---|
Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.
Topics: Administration, Oral; Adult; Ascorbic Acid; Body Mass Index; Chalcone; Chronic Disease; Drug Therapy, Combination; Female; Hesperidin; Humans; Male; Mexico; Middle Aged; Obesity; Plant Extracts; Prospective Studies; Quality of Life; Ruscus; Surveys and Questionnaires; Vascular Diseases | 2009 |
5 other study(ies) available for chalcone and Obesity
| Article | Year |
|---|---|
Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.
Topics: Animals; Body Weight; Chalcone; Diet, High-Fat; Leptin; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Quinones | 2022 |
Safflower yellow improves insulin sensitivity in high-fat diet-induced obese mice by promoting peroxisome proliferator-activated receptor-γ2 expression in subcutaneous adipose tissue.
Topics: Animals; Chalcone; Diet, High-Fat; Gene Expression Regulation; Insulin Resistance; Male; Mice; Mice, Inbred ICR; Mice, Obese; Obesity; PPAR gamma; Subcutaneous Fat | 2020 |
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
Topics: Adiposity; Administration, Oral; Animals; Anti-Obesity Agents; Bacteria; Biomarkers; Blood Glucose; Chalcone; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Fatty Acids, Volatile; Gastrointestinal Microbiome; Insulin; Insulin Resistance; Intestines; Male; Metabolomics; Mice, Inbred C57BL; Obesity; Quinones; Weight Loss | 2018 |
Acarbose versus trans-chalcone: comparing the effect of two glycosidase inhibitors on obese mice.
Topics: Acarbose; Adipocytes; Adipokines; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Body Weight; Chalcone; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Glycoside Hydrolase Inhibitors; Hepatocytes; Lipids; Liver; Male; Mice, Obese; Obesity; Reproducibility of Results; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Xanthoangelol and 4-hydroxyderrcin suppress obesity-induced inflammatory responses.
Topics: Adipocytes; Angelica; Animals; Cell Differentiation; Chalcone; Coculture Techniques; Culture Media, Conditioned; Diet, High-Fat; Inflammation; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Obesity; Phosphorylation; Phytotherapy; Plant Extracts; Transcription Factor AP-1 | 2016 |